{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:57:28Z","timestamp":1768712248702,"version":"3.49.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pelotonia Graduate Fellowship, The Ohio State Univerisity"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0226714","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T13:36:45Z","timestamp":1577367405000},"page":"e0226714","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0181-436X","authenticated-orcid":true,"given":"Dongju","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Shakya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Koivisto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason R.","family":"Pitarresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Szabolcs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raleigh","family":"Kladney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Hadjis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Mace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,12,26]]},"reference":[{"key":"pone.0226714.ref001","article-title":"Cancer statistics, 2019","author":"RL Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"pone.0226714.ref002","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.seminoncol.2016.09.002","article-title":"Familial pancreatic cancer","volume":"43","author":"GM Petersen","year":"2016","journal-title":"Semin Oncol"},{"issue":"7","key":"pone.0226714.ref003","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/gim.2014.153","article-title":"BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study","volume":"17","author":"DB Zhen","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"pone.0226714.ref004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10689-011-9426-1","article-title":"PALB2 mutations in familial breast and pancreatic cancer","volume":"10","author":"EW Hofstatter","year":"2011","journal-title":"Fam Cancer"},{"issue":"2","key":"pone.0226714.ref005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cancergencyto.2004.01.032","article-title":"BRCA1 and pancreatic cancer: pedigree findings and their causal relationships","volume":"158","author":"HT Lynch","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"issue":"15","key":"pone.0226714.ref006","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","author":"Breast Cancer Linkage C.","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"5924","key":"pone.0226714.ref007","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1171202","article-title":"Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene","volume":"324","author":"S Jones","year":"2009","journal-title":"Science"},{"issue":"7592","key":"pone.0226714.ref008","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"P Bailey","year":"2016","journal-title":"Nature"},{"issue":"6559","key":"pone.0226714.ref009","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"R Wooster","year":"1995","journal-title":"Nature"},{"issue":"5181","key":"pone.0226714.ref010","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"R Wooster","year":"1994","journal-title":"Science"},{"issue":"13","key":"pone.0226714.ref011","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.92.13.5950","article-title":"Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region","volume":"92","author":"M Schutte","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"pone.0226714.ref012","first-page":"5360","article-title":"Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas","volume":"56","author":"M Goggins","year":"1996","journal-title":"Cancer Res"},{"issue":"1","key":"pone.0226714.ref013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng0597-17","article-title":"Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients","volume":"16","author":"H Ozcelik","year":"1997","journal-title":"Nat Genet"},{"issue":"3","key":"pone.0226714.ref014","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jnci\/95.3.214","article-title":"BRCA2 germline mutations in familial pancreatic carcinoma","volume":"95","author":"SA Hahn","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"pone.0226714.ref015","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4161\/cbt.11.11.15534","article-title":"Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer","volume":"11","author":"G Feldmann","year":"2011","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"pone.0226714.ref016","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/j.gastro.2010.12.039","article-title":"Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice","volume":"140","author":"M Rowley","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"pone.0226714.ref017","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ccr.2010.10.015","article-title":"Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer","volume":"18","author":"F Skoulidis","year":"2010","journal-title":"Cancer Cell"},{"issue":"18","key":"pone.0226714.ref018","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer Incidence in BRCA1 mutation carriers","volume":"94","author":"D Thompson","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"pone.0226714.ref019","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10549-017-4500-5","article-title":"A frameshift mutation in BRCA1 leads to hereditary breast and ovarian cancer in one part of a family and to familial pancreatic cancer in another","volume":"167","author":"L Gieldon","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"6055","key":"pone.0226714.ref020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1209909","article-title":"BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity","volume":"334","author":"R Shakya","year":"2011","journal-title":"Science"},{"issue":"6","key":"pone.0226714.ref021","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","article-title":"Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2","volume":"22","author":"B Xia","year":"2006","journal-title":"Mol Cell"},{"issue":"5897","key":"pone.0226714.ref022","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"S Jones","year":"2008","journal-title":"Science"},{"issue":"5","key":"pone.0226714.ref023","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cancergen.2016.03.003","article-title":"Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic","volume":"209","author":"M Borecka","year":"2016","journal-title":"Cancer Genet"},{"issue":"6","key":"pone.0226714.ref024","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cub.2009.02.018","article-title":"PALB2 links BRCA1 and BRCA2 in the DNA-damage response","volume":"19","author":"F Zhang","year":"2009","journal-title":"Curr Biol"},{"issue":"2","key":"pone.0226714.ref025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1158\/2159-8290.CD-14-1156","article-title":"Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype","volume":"5","author":"SL Sawyer","year":"2015","journal-title":"Cancer Discov"},{"issue":"5581","key":"pone.0226714.ref026","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.1073834","article-title":"Biallelic inactivation of BRCA2 in Fanconi anemia","volume":"297","author":"NG Howlett","year":"2002","journal-title":"Science"},{"issue":"2","key":"pone.0226714.ref027","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","article-title":"Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer","volume":"39","author":"S Reid","year":"2007","journal-title":"Nat Genet"},{"issue":"43","key":"pone.0226714.ref028","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1038\/sj.onc.1209878","article-title":"Fanconi anaemia genes and susceptibility to cancer","volume":"25","author":"CG Mathew","year":"2006","journal-title":"Oncogene"},{"issue":"19","key":"pone.0226714.ref029","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1073\/pnas.0711032105","article-title":"The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1\/BARD1 heterodimer in tumor suppression","volume":"105","author":"R Shakya","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"pone.0226714.ref030","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1038\/sj.onc.1204512","article-title":"Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice","volume":"20","author":"T Ludwig","year":"2001","journal-title":"Oncogene"},{"issue":"8","key":"pone.0226714.ref031","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1158\/2159-8290.CD-13-0011","article-title":"Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer","volume":"3","author":"Y Huo","year":"2013","journal-title":"Cancer Discov"},{"issue":"1","key":"pone.0226714.ref032","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/s41467-018-05266-6","article-title":"Stromal PTEN determines mammary epithelial response to radiotherapy","volume":"9","author":"GM Sizemore","year":"2018","journal-title":"Nat Commun"},{"issue":"15","key":"pone.0226714.ref033","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/hmg\/ddq207","article-title":"Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice","volume":"19","author":"P Rantakari","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"6627","key":"pone.0226714.ref034","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/386804a0","article-title":"Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2","volume":"386","author":"SK Sharan","year":"1997","journal-title":"Nature"},{"issue":"2","key":"pone.0226714.ref035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ng0296-191","article-title":"Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities","volume":"12","author":"LC Gowen","year":"1996","journal-title":"Nat Genet"},{"issue":"6","key":"pone.0226714.ref036","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/er.2007-0016","article-title":"An illustrated review of early pancreas development in the mouse","volume":"28","author":"MC J\u00f8rgensen","year":"2007","journal-title":"Endocr Rev"},{"issue":"7","key":"pone.0226714.ref037","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0092-8674(00)81302-1","article-title":"The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse","volume":"85","author":"R Hakem","year":"1996","journal-title":"Cell"},{"issue":"10","key":"pone.0226714.ref038","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1101\/gad.11.10.1242","article-title":"Brca2 is required for embryonic cellular proliferation in the mouse","volume":"11","author":"A Suzuki","year":"1997","journal-title":"Genes Dev"},{"issue":"6","key":"pone.0226714.ref039","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","article-title":"Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome","volume":"119","author":"KP Olive","year":"2004","journal-title":"Cell"},{"issue":"5","key":"pone.0226714.ref040","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1073\/pnas.052713099","article-title":"Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function","volume":"99","author":"A de Vries","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"pone.0226714.ref041","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc2899","article-title":"KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma","volume":"10","author":"JP Morris","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"pone.0226714.ref042","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5009\/gnl.2008.2.3.137","article-title":"Precursor lesions of pancreatic cancer","volume":"2","author":"S Yonezawa","year":"2008","journal-title":"Gut Liver"},{"issue":"6","key":"pone.0226714.ref043","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"SR Hingorani","year":"2003","journal-title":"Cancer Cell"},{"issue":"6","key":"pone.0226714.ref044","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2007.09.009","article-title":"In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia","volume":"133","author":"O Strobel","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"pone.0226714.ref045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrgastro.2011.2","article-title":"Cystic precursors to invasive pancreatic cancer","volume":"8","author":"H Matthaei","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"pone.0226714.ref046","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.semdp.2006.04.005","article-title":"Cystic, mucin-producing neoplasms of the pancreas: the distinguishing features of mucinous cystic neoplasms and intraductal papillary mucinous neoplasms","volume":"22","author":"DS Klimstra","year":"2005","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"pone.0226714.ref047","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrm2851","article-title":"Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis","volume":"11","author":"ME Moynahan","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"pone.0226714.ref048","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/bjc.2015.220","article-title":"BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts","volume":"113","author":"I Lohse","year":"2015","journal-title":"Br J Cancer"},{"issue":"9","key":"pone.0226714.ref049","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091886","article-title":"The Role of PALB2 in the DNA Damage Response and Cancer Predisposition","volume":"18","author":"TC Nepomuceno","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"7035","key":"pone.0226714.ref050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"HE Bryant","year":"2005","journal-title":"Nature"},{"issue":"7035","key":"pone.0226714.ref051","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"H Farmer","year":"2005","journal-title":"Nature"},{"issue":"31","key":"pone.0226714.ref052","doi-asserted-by":"crossref","first-page":"23899","DOI":"10.1074\/jbc.C000276200","article-title":"The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin","volume":"275","author":"A Bhattacharyya","year":"2000","journal-title":"J Biol Chem"},{"issue":"26","key":"pone.0226714.ref053","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"JR Brahmer","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0226714.ref054","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ags3.12176","article-title":"Immunotherapy for pancreatic cancer: Barriers and breakthroughs","volume":"2","author":"RJ Torphy","year":"2018","journal-title":"Ann Gastroenterol Surg"},{"issue":"2","key":"pone.0226714.ref055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/gutjnl-2016-311585","article-title":"IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer","volume":"67","author":"TA Mace","year":"2018","journal-title":"Gut"},{"issue":"4","key":"pone.0226714.ref056","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1158\/2159-8290.CD-12-0421","article-title":"Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer","volume":"3","author":"SM Domchek","year":"2013","journal-title":"Cancer Discov"},{"issue":"5","key":"pone.0226714.ref057","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","article-title":"Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2","volume":"12","author":"N Petrucelli","year":"2010","journal-title":"Genet Med"},{"issue":"7","key":"pone.0226714.ref058","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1158\/1541-7786.MCR-09-0123","article-title":"PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2","volume":"7","author":"F Zhang","year":"2009","journal-title":"Mol Cancer Res"},{"issue":"17","key":"pone.0226714.ref059","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1073\/pnas.0811159106","article-title":"PALB2 is an integral component of the BRCA complex required for homologous recombination repair","volume":"106","author":"SM Sy","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"pone.0226714.ref060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L","article-title":"Mosaic Cre-mediated recombination in pancreas using the pdx-1 enhancer\/promoter","volume":"26","author":"M Gannon","year":"2000","journal-title":"Genesis"},{"key":"pone.0226714.ref061","first-page":"5619358","article-title":"Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations","volume":"2016","author":"E Chahla","year":"2016","journal-title":"Scientifica (Cairo)"},{"key":"pone.0226714.ref062","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrc1457","article-title":"Hallmarks of 'BRCAness' in sporadic cancers","volume":"4","author":"N Turner","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"pone.0226714.ref063","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"CJ Lord","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"pone.0226714.ref064","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1158\/1055-9965.EPI-05-0971","article-title":"Loss of heterozygosity at the BRCA1 and BRCA2 loci detected in ductal lavage fluid from BRCA gene mutation carriers and controls","volume":"15","author":"I Locke","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"pone.0226714.ref065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1897-4287-12-19","article-title":"Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and\/or ovarian cancer families from Eastern Ontario, Canada","volume":"12","author":"T Hartley","year":"2014","journal-title":"Hered Cancer Clin Pract"},{"issue":"1","key":"pone.0226714.ref066","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/path.2861","article-title":"Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression","volume":"224","author":"P Bouwman","year":"2011","journal-title":"J Pathol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T13:37:29Z","timestamp":1577367449000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226714"}},"subtitle":[],"editor":[{"given":"Alvaro","family":"Galli","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,26]]},"references-count":66,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0226714","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,26]]}}}